{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:23:27Z","timestamp":1740029007446,"version":"3.37.3"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1124\/jpet.108.139733","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:33:40Z","timestamp":1214872420000},"page":"168-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["1-[1-Hexyl-6-(methyloxy)-1 H-indazol-3-yl]-2-methyl-1-propanone, a Potent and Highly Selective Small Molecule Blocker of the Large-Conductance Voltage-Gated and Calcium-Dependent K+ Channel"],"prefix":"10.1016","volume":"327","author":[{"given":"Haoyu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Earl","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuojun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina M.","family":"Lozinskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Willette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.139733_bib1","doi-asserted-by":"crossref","unstructured":"Atkinson NS, Robertson GA, and Ganetzky B (1991) A component of calcium-activated potassium channels encoded by the Drosophila slo locus. Science 253: 551-555.","DOI":"10.1126\/science.1857984"},{"key":"10.1124\/jpet.108.139733_bib2","doi-asserted-by":"crossref","unstructured":"Brenner R, Chen QH, Vilaythong A, Toney GM, Noebels JL, and Aldrich RW (2005) BK channel beta4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures. Nat Neurosci 8: 1752-1759.","DOI":"10.1038\/nn1573"},{"key":"10.1124\/jpet.108.139733_bib3","doi-asserted-by":"crossref","unstructured":"Brenner R, Jegla TJ, Wickenden A, Liu Y, and Aldrich RW (2000a) Cloning and functional characterization of novel large conductance calcium-activated potassium channel beta subunits, hKCNMB3 and hKCNMB4. J Biol Chem 275: 6453-6461.","DOI":"10.1074\/jbc.275.9.6453"},{"key":"10.1124\/jpet.108.139733_bib4","doi-asserted-by":"crossref","unstructured":"Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, and Aldrich RW. Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature 407: 870-876, 2000b.","DOI":"10.1038\/35038011"},{"key":"10.1124\/jpet.108.139733_bib5","unstructured":"Doherty JB, Chen M-H, Liu L, Natarajan SR, and Tynerbor RM (2004) Ophthalmic compositions for treating ocular hypertension. U.S. patent application 2004\/0097575 A1."},{"key":"10.1124\/jpet.108.139733_bib6","doi-asserted-by":"crossref","unstructured":"Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowski GJ, and Garcia ML (1990) Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem 265: 11083-11090.","DOI":"10.1016\/S0021-9258(19)38560-6"},{"key":"10.1124\/jpet.108.139733_bib7","doi-asserted-by":"crossref","unstructured":"Garcia-Calvo M, Knaus HG, McManus OB, Giangiacomo KM, Kaczorowski GJ, and Garcia ML (1994) Purification and reconstitution of the high-conductance, calcium-activated potassium channel from tracheal smooth muscle. J Biol Chem 269: 676-682.","DOI":"10.1016\/S0021-9258(17)42402-1"},{"key":"10.1124\/jpet.108.139733_bib8","doi-asserted-by":"crossref","unstructured":"Garcia-Valdes J, Zamudio FZ, Toro L, and Possani LD (2001) Slotoxin, alphaKTx1.11, a new scorpion peptide blocker of MaxiK channels that differentiates between alpha and alpha+beta (beta1 or beta4) complexes. FEBS Lett 505: 369-373.","DOI":"10.1016\/S0014-5793(01)02791-0"},{"key":"10.1124\/jpet.108.139733_bib9","doi-asserted-by":"crossref","unstructured":"Ghatta S, Lozinskaya I, Lin Z, Gordon E, Willette RN, Brooks DP, and Xu X (2007) Acetic acid opens large-conductance Ca2+-activated K+ channels in guinea pig detrusor smooth muscle cells. Eur J Pharmacol 563: 203-208.","DOI":"10.1016\/j.ejphar.2007.02.037"},{"key":"10.1124\/jpet.108.139733_bib10","doi-asserted-by":"crossref","unstructured":"Ghatta S, Nimmagadda D, Xu X, and O\u2019Rourke ST (2006) Large-conductance, calcium-activated potassium channels: structural and functional implications. Pharmacol Ther 110: 103-116.","DOI":"10.1016\/j.pharmthera.2005.10.007"},{"key":"10.1124\/jpet.108.139733_bib11","doi-asserted-by":"crossref","unstructured":"Giangiacomo KM, Garcia ML, and McManus OB (1992) Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle. Biochemistry 31: 6719-6727.","DOI":"10.1021\/bi00144a011"},{"key":"10.1124\/jpet.108.139733_bib12","doi-asserted-by":"crossref","unstructured":"Heppner TJ, Bonev AD, and Nelson MT (1997) Ca(2+)-activated K+ channels regulate action potential repolarization in urinary bladder smooth muscle. Am J Physiol Cell Physiol 273: C110-C117.","DOI":"10.1152\/ajpcell.1997.273.1.C110"},{"key":"10.1124\/jpet.108.139733_bib13","unstructured":"Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC."},{"key":"10.1124\/jpet.108.139733_bib14","doi-asserted-by":"crossref","unstructured":"Knaus HG, Garcia-Calvo M, Kaczorowski GJ, and Garcia ML (1994a) Subunit composition of the high conductance calcium-activated potassium channel from smooth muscle, a representative of the mSlo and slowpoke family of potassium channels. J Biol Chem 269: 3921-3924.","DOI":"10.1016\/S0021-9258(17)41720-0"},{"key":"10.1124\/jpet.108.139733_bib15","doi-asserted-by":"crossref","unstructured":"Knaus HG, McManus OB, Lee SH, Schmalhofer WA, Garcia-Calvo M, Helms LM, Sanchez M, Giangiacomo K, Reuben JP, Smith AB 3rd, et al. (1994b) Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry 33: 5819-5828.","DOI":"10.1021\/bi00185a021"},{"key":"10.1124\/jpet.108.139733_bib16","doi-asserted-by":"crossref","unstructured":"Lippiat JD, Standen NB, Harrow ID, Phillips SC, and Davies NW (2003) Properties of BK(Ca) channels formed by bicistronic expression of hSloalpha and beta1\u20134 subunits in HEK293 cells. J Membr Biol 192: 141-148.","DOI":"10.1007\/s00232-002-1070-0"},{"key":"10.1124\/jpet.108.139733_bib17","doi-asserted-by":"crossref","unstructured":"McManus OB, Helms LM, Pallanck L, Ganetzky B, Swanson R, and Leonard RJ (1995) Functional role of the beta subunit of high conductance calcium-activated potassium channels. Neuron 14: 645-650.","DOI":"10.1016\/0896-6273(95)90321-6"},{"key":"10.1124\/jpet.108.139733_bib18","doi-asserted-by":"crossref","unstructured":"Meera P, Wallner M, and Toro L (2000) A neuronal beta subunit (KCNMB4) makes the large conductance, voltage- and Ca2+-activated K+ channel resistant to charybdotoxin and iberiotoxin. Proc Natl Acad Sci U S A 97: 5562-5567.","DOI":"10.1073\/pnas.100118597"},{"key":"10.1124\/jpet.108.139733_bib19","doi-asserted-by":"crossref","unstructured":"Miller C, Moczydlowski E, Latorre R, and Phillips M (1985) Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle. Nature 313: 316-318.","DOI":"10.1038\/313316a0"},{"key":"10.1124\/jpet.108.139733_bib20","doi-asserted-by":"crossref","unstructured":"Rials SJ, Wu Y, Xu X, Filart RA, Marinchak RA, and Kowey PR (1997) Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation 96: 1330-1336.","DOI":"10.1161\/01.CIR.96.4.1330"},{"key":"10.1124\/jpet.108.139733_bib21","doi-asserted-by":"crossref","unstructured":"Sanchez M and McManus OB (1996) Paxilline inhibition of the alpha-subunit of the high-conductance calcium-activated potassium channel. Neuropharmacology 35: 963-968.","DOI":"10.1016\/0028-3908(96)00137-2"},{"key":"10.1124\/jpet.108.139733_bib22","doi-asserted-by":"crossref","unstructured":"Shieh CC, Turner SC, Zhang XF, Milicic I, Parihar A, Jinkerson T, Wilkins J, Buckner SA, and Gopalakrishnan M (2007) A-272651, a nonpeptidic blocker of large-conductance Ca(2+)-activated K(+) channels, modulates bladder smooth muscle contractility and neuronal action potentials. Br J Pharmacol 151: 798-806.","DOI":"10.1038\/sj.bjp.0707278"},{"key":"10.1124\/jpet.108.139733_bib23","doi-asserted-by":"crossref","unstructured":"Tammaro P, Smith AL, Hutchings SR, and Smirnov SV (2004) Pharmacological evidence for a key role of voltage-gated K+ channels in the function of rat aortic smooth muscle cells. Br J Pharmacol 143: 303-317.","DOI":"10.1038\/sj.bjp.0705957"},{"key":"10.1124\/jpet.108.139733_bib24","doi-asserted-by":"crossref","unstructured":"Wallner M, Meera P, and Toro L (1999) Molecular basis of fast inactivation in voltage and Ca2+-activated K+ channels: a transmembrane beta-subunit homolog. Proc Natl Acad Sci U S A 96: 4137-4142.","DOI":"10.1073\/pnas.96.7.4137"},{"key":"10.1124\/jpet.108.139733_bib25","doi-asserted-by":"crossref","unstructured":"Wang G and Lemos JR (1995) Tetrandrine: a new ligand to block voltage-dependent Ca2+ and Ca(+)-activated K+ channels. Life Sci 56: 295-306.","DOI":"10.1016\/0024-3205(94)00952-X"},{"key":"10.1124\/jpet.108.139733_bib26","doi-asserted-by":"crossref","unstructured":"Wu SN, Li HF, and Lo YC (2000) Characterization of tetrandrine-induced inhibition of large-conductance calcium-activated potassium channels in a human endothelial cell line (HUV-EC-C). J Pharmacol Exp Ther 292: 188-195.","DOI":"10.1016\/S0022-3565(24)35276-0"},{"key":"10.1124\/jpet.108.139733_bib27","doi-asserted-by":"crossref","unstructured":"Xia XM, Ding JP, and Lingle CJ (2003) Inactivation of BK channels by the NH2 terminus of the beta2 auxiliary subunit: an essential role of a terminal peptide segment of three hydrophobic residues. J Gen Physiol 121: 125-148.","DOI":"10.1085\/jgp.20028667"},{"key":"10.1124\/jpet.108.139733_bib28","doi-asserted-by":"crossref","unstructured":"Xia XM, Ding JP, Zeng XH, Duan KL, and Lingle CJ (2000) Rectification and rapid activation at low Ca2+ of Ca2+-activated, voltage-dependent BK currents: consequences of rapid inactivation by a novel beta subunit. J Neurosci 20: 4890-4903.","DOI":"10.1523\/JNEUROSCI.20-13-04890.2000"},{"key":"10.1124\/jpet.108.139733_bib29","doi-asserted-by":"crossref","unstructured":"Xu CQ, Br\u00f4ne B, Wicher D, Bozkurt O, Lu WY, Huys I, Han YH, Tytgat J, Van Kerkhove E, and Chi CW (2004) BmBKTx1, a novel Ca2+-activated K+ channel blocker purified from the Asian scorpion Buthus martensi Karsch. J Biol Chem 279: 34562-34569.","DOI":"10.1074\/jbc.M312798200"},{"key":"10.1124\/jpet.108.139733_bib30","doi-asserted-by":"crossref","unstructured":"Yao J, Chen X, Li H, Zhou Y, Yao L, Wu G, Chen X, Zhang N, Zhou Z, Xu T, et al. (2005) BmP09, a \u201clong chain\u201d scorpion peptide blocker of BK channels. J Biol Chem 280: 14819-14828.","DOI":"10.1074\/jbc.M412735200"},{"key":"10.1124\/jpet.108.139733_bib31","doi-asserted-by":"crossref","unstructured":"Zeng H, Lozinskaya IM, Lin Z, Willette RN, Brooks DP, and Xu X (2006) Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator. J Pharmacol Exp Ther 319: 957-962.","DOI":"10.1124\/jpet.106.110593"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524346269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524346269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.139733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:45:42Z","timestamp":1740005142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524346269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0022356524346269"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.139733","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1-[1-Hexyl-6-(methyloxy)-1 H-indazol-3-yl]-2-methyl-1-propanone, a Potent and Highly Selective Small Molecule Blocker of the Large-Conductance Voltage-Gated and Calcium-Dependent K+ Channel","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.139733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}